Table 2.
Clinical efficacy assessment
| Group | Effective Treatment | Improvement | Ineffective Treatment | Total efficiency |
|---|---|---|---|---|
| Control group (n=64) | 28 | 21 | 15 | 49 (76.56%) |
| Observation group (n=76) | 46 | 24 | 6 | 70 (92.10%) |
| χZ/2 values | 2.431 | 6.583 | ||
| P-value | 0.015 | 0.010 | ||
Clinical efficacy assessment
| Group | Effective Treatment | Improvement | Ineffective Treatment | Total efficiency |
|---|---|---|---|---|
| Control group (n=64) | 28 | 21 | 15 | 49 (76.56%) |
| Observation group (n=76) | 46 | 24 | 6 | 70 (92.10%) |
| χZ/2 values | 2.431 | 6.583 | ||
| P-value | 0.015 | 0.010 | ||